PatSnap, the leading provider of innovation intelligence solutions, has announced the upcoming release of its latest AI-powered GPT product . Developed to revolutionize IP and R&D innovation services, PatSnapGPT boasts three groundbreaking fea…
Merck & Co is pushing forward with its Phase 3 program to test the efficacy of MK-0616, an oral cholesterol-lowering drug that has shown promise in mid-stage trials by matching the effects of approved injectable competitors. This developme…
On April 4 , Wisdom Buds announced that its latest AI product " Smart Buds GPT" will be released soon. Three breakthrough functions based on the GPT technology will also be launched simultaneously, namely " …
